RayzeBio Inc.

RayzeBio Inc.

World Rank (Jan-05-2024)

3,716

Market Cap (Jan-05-2024)

3.711 Billion USD

World Rank (Jul-30-2023)

7,834

Market Cap (Jul-30-2023)

1.205 Billion USD

Headquarters Country

Nasdaq / NYSE Code

RYZB

Headquarters City/State

World Region

World Subregion

Northern America

Business Sector

Company Website

Yahoo

Company Profile

RayzeBio is building a vertically integrated radiopharmaceutical therapeutics (RPT) company to treat various cancers, with its lead program in a Phase 3 clinical trial. Headquarters is in USA.

IPO Year

2023

Stock Exchange

Share